(Q37829904)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245832%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

review article

1 reference

title

Serologic antiglycan antibodies in inflammatory bowel disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245832%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

20 January 2020

main subject

0 references

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245832%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Maria Papp

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245832%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Florian Rieder

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245832%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

English

0 references

publication date

18 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245832%20AND%20SRC:MED&resulttype=core&format=json

The American Journal of Gastroenterology

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245832%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245832%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245832%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

406-412

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21245832%20AND%20SRC:MED&resulttype=core&format=json

European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Germline MLH1 and MSH2 mutational spectrum including frequent large genomic aberrations in Hungarian hereditary non-polyposis colorectal cancer families: implications for genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Unravelling the pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Increased immune reactivity predicts aggressive complicating Crohn's disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Interaction between seroreactivity to microbial antigens and genetics in Crohn's disease: is there a role for defensins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Utility of serum antibodies in determining clinical course in pediatric Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Ileal pouch-anal anastomosis in patients with indeterminate colitis: long-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

The value of serologic markers in indeterminate colitis: a prospective follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

New serological markers in inflammatory bowel disease are associated with complicated disease behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Serological markers in inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Long-term evolution of disease behavior of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Effect of phenotype on health care costs in Crohn’s disease: A European study using the Montreal classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Risk factors for initial surgery in pediatric patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Novel Anti-Glycan Antibodies Related to Inflammatory Bowel Disease Diagnosis and Phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Serum anti-glycan antibodies predict complicated Crohn's disease behavior: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohnʼs disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Elevated serum anti-Saccharomyces cerevisiae, anti-I2 and anti-OmpW antibody levels in patients with suspicion of celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Anti-microbial antibodies in celiac disease: trick or treat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Bacterial translocation (BT) in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505

Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.505